DE69837279D1 - Neue metall-komplexe - Google Patents
Neue metall-komplexeInfo
- Publication number
- DE69837279D1 DE69837279D1 DE69837279T DE69837279T DE69837279D1 DE 69837279 D1 DE69837279 D1 DE 69837279D1 DE 69837279 T DE69837279 T DE 69837279T DE 69837279 T DE69837279 T DE 69837279T DE 69837279 D1 DE69837279 D1 DE 69837279D1
- Authority
- DE
- Germany
- Prior art keywords
- metal complexes
- new metal
- new
- complexes
- metal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Revoked
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/315—Zinc compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic System
- C07F3/003—Compounds containing elements of Groups 2 or 12 of the Periodic System without C-Metal linkages
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6395797P | 1997-10-31 | 1997-10-31 | |
US63957P | 1997-10-31 | ||
PCT/US1998/023186 WO1999022733A1 (en) | 1997-10-31 | 1998-10-30 | Novel metal complexes |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69837279D1 true DE69837279D1 (de) | 2007-04-19 |
DE69837279T2 DE69837279T2 (de) | 2007-11-15 |
Family
ID=22052594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69837279T Revoked DE69837279T2 (de) | 1997-10-31 | 1998-10-30 | Neue metall-komplexe |
Country Status (8)
Country | Link |
---|---|
US (2) | US6280959B1 (de) |
EP (1) | EP1032387B1 (de) |
JP (1) | JP2001521896A (de) |
AU (1) | AU738473B2 (de) |
CA (1) | CA2308317A1 (de) |
DE (1) | DE69837279T2 (de) |
ES (1) | ES2284217T3 (de) |
WO (1) | WO1999022733A1 (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2308135A1 (en) * | 1997-10-31 | 1999-05-14 | John G. Gleason | Novel metal complexes |
ES2257090T3 (es) | 1998-11-17 | 2006-07-16 | Smithkline Beecham Corporation | Poliamidas ciclicas para tratar trombocitopenia. |
WO2001050127A2 (en) * | 1999-12-30 | 2001-07-12 | 7Tm Pharma | Screening using biological target molecules with metal-ion binding sites |
US20110212054A1 (en) * | 2000-05-25 | 2011-09-01 | Glaxosmithkline Llc. | Thrombopoietin mimetics |
CY2010012I2 (el) * | 2000-05-25 | 2020-05-29 | Novartis Ag | Μιμητικα θρομβοποιητινης |
WO2002054077A2 (en) * | 2000-12-29 | 2002-07-11 | 7Tm Pharma A/S | Validating biological molecules as drug targets by metal-ion chelates in animal test models |
AR040083A1 (es) | 2002-05-22 | 2005-03-16 | Smithkline Beecham Corp | Compuesto bis-(monoetanolamina) del acido 3'-[(2z)-[1-(3,4-dimetilfenil) -1,5-dihidro-3-metil-5-oxo-4h-pirazol-4-iliden] hidrazino] -2'-hidroxi-[1,1'-bifenil]-3-carboxilico, procedimiento para prepararlo, composicion farmaceutica que lo comprende, procedimiento para preparar dicha composicion farmac |
US20100004302A1 (en) * | 2003-04-29 | 2010-01-07 | Connie Erickson-Miller | Methods for Treating Degenerative Diseases/Injuries |
US20090298179A1 (en) * | 2003-04-29 | 2009-12-03 | Connie Erickson-Miller | Methods For Treating Degenerative Diseases/Injuries |
US20090048318A1 (en) * | 2003-04-29 | 2009-02-19 | Connie Erickson-Miller | Methods for treating degenerative diseases/injuries |
WO2004096154A2 (en) * | 2003-04-29 | 2004-11-11 | Smithkline Beecham Corporation | Methods for treating degenerative diseases/injuries |
US20090143453A1 (en) * | 2003-04-29 | 2009-06-04 | Connie Erickson-Miller | Methods for treating degenerative diseases/injuries |
TW200526638A (en) * | 2003-10-22 | 2005-08-16 | Smithkline Beecham Corp | 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'-(1H-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline |
US8048870B2 (en) * | 2005-01-11 | 2011-11-01 | Batarseh Kareem I | Apoptosis-inducing antineoplastic silver (I) coordination complexes |
US20110129550A1 (en) | 2007-02-16 | 2011-06-02 | Connie Erickson-Miller | Cancer treatment method |
ECSP077628A (es) * | 2007-05-03 | 2008-12-30 | Smithkline Beechman Corp | Nueva composición farmacéutica |
KR101530402B1 (ko) | 2007-10-09 | 2015-06-19 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | 급성 인간 골수성 백혈병 세포를 죽이는 트롬보포이에틴 수용체 효능제 (tpora) |
JP2012528184A (ja) | 2009-05-29 | 2012-11-12 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | トロンボポエチンアゴニスト化合物の投与の方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1988001509A1 (en) * | 1986-08-25 | 1988-03-10 | Chemex Pharmaceuticals, Inc. | Pharmacologically active compositions of catecholic butanes with zinc |
AU1757092A (en) * | 1991-03-28 | 1992-11-02 | Genentech Inc. | Stable growth hormone metal ion formulations |
TW233264B (de) * | 1992-02-03 | 1994-11-01 | Otsuka Pharma Co Ltd | |
US5773569A (en) | 1993-11-19 | 1998-06-30 | Affymax Technologies N.V. | Compounds and peptides that bind to the erythropoietin receptor |
US5830851A (en) | 1993-11-19 | 1998-11-03 | Affymax Technologies N.V. | Methods of administering peptides that bind to the erythropoietin receptor |
US5693515A (en) | 1995-04-28 | 1997-12-02 | Arris Pharmaceutical Corporation | Metal complexed serine protease inhibitors |
US5767078A (en) | 1995-06-07 | 1998-06-16 | Johnson; Dana L. | Agonist peptide dimers |
US5869451A (en) | 1995-06-07 | 1999-02-09 | Glaxo Group Limited | Peptides and compounds that bind to a receptor |
CZ376798A3 (cs) * | 1996-05-22 | 1999-04-14 | Smithkline Beecham Corporation | Nepeptidové látky podobné G-CSF |
WO1999022732A1 (en) * | 1997-10-31 | 1999-05-14 | Smithkline Beecham Corporation | Novel metal complexes |
CA2308135A1 (en) * | 1997-10-31 | 1999-05-14 | John G. Gleason | Novel metal complexes |
-
1998
- 1998-10-30 US US09/530,307 patent/US6280959B1/en not_active Expired - Lifetime
- 1998-10-30 ES ES98956426T patent/ES2284217T3/es not_active Expired - Lifetime
- 1998-10-30 DE DE69837279T patent/DE69837279T2/de not_active Revoked
- 1998-10-30 CA CA002308317A patent/CA2308317A1/en not_active Abandoned
- 1998-10-30 AU AU12951/99A patent/AU738473B2/en not_active Expired
- 1998-10-30 WO PCT/US1998/023186 patent/WO1999022733A1/en active IP Right Grant
- 1998-10-30 US US09/183,974 patent/US20010016568A1/en not_active Abandoned
- 1998-10-30 JP JP2000518666A patent/JP2001521896A/ja active Pending
- 1998-10-30 EP EP98956426A patent/EP1032387B1/de not_active Revoked
Also Published As
Publication number | Publication date |
---|---|
EP1032387A1 (de) | 2000-09-06 |
DE69837279T2 (de) | 2007-11-15 |
US20010016568A1 (en) | 2001-08-23 |
CA2308317A1 (en) | 1999-05-14 |
WO1999022733A1 (en) | 1999-05-14 |
AU1295199A (en) | 1999-05-24 |
US6280959B1 (en) | 2001-08-28 |
EP1032387B1 (de) | 2007-03-07 |
US20010014454A1 (en) | 2001-08-16 |
JP2001521896A (ja) | 2001-11-13 |
EP1032387A4 (de) | 2004-02-11 |
ES2284217T3 (es) | 2007-11-01 |
AU738473B2 (en) | 2001-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE59812192D1 (de) | Bleichaktive Metall-Komplexe | |
NO994875L (no) | Forbundne metallkomplekser | |
ATE355264T1 (de) | Neue aryloxy-alkyl-dialkylamine | |
ATE261964T1 (de) | Neue antiarrhytmische bispidin-verbindungen | |
DE69726277D1 (de) | Überbasische metallenthaltende detergens | |
DE69809739D1 (de) | Organometallische komplexe | |
DE69812069D1 (de) | Metallhalogenidlampe | |
EP1032388A4 (de) | Neue metallkomplexe | |
DE69807759T2 (de) | Metall-Laminatdichtung | |
DE69812454T2 (de) | Metalldichtung | |
DE69808017D1 (de) | D-Prolinderivate | |
DE69937730D1 (de) | Metallfilter | |
DE69837279D1 (de) | Neue metall-komplexe | |
DE59904144D1 (de) | Neue Metallkomplexpigmente | |
DE69825700D1 (de) | Metallhalogenidlampe | |
DE69707553T2 (de) | Metallhalogenidlampe | |
DE69536102D1 (de) | Neue streptogramine | |
DE69824201D1 (de) | Neue 9a-azalide | |
DE69713471T2 (de) | Substituierte benzoldithiol-metallkomplexe | |
DE69733049D1 (de) | Metallhalogenidlampe | |
DE69804593T2 (de) | Neue isocyanat-beendete präpolymere | |
NO20002159D0 (no) | Piperazin-cyklodekstrin-komplekser | |
DE50014688D1 (de) | Bleichaktive Metallkomplexe | |
ATE210661T1 (de) | Neue tetrahydroiosoquinolin thiophenecarboximidamiden | |
DK0926953T3 (da) | Halogenpropargylinkonklusionskomplekser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent | ||
8331 | Complete revocation |